Entrada Therapeutics (TRDA) Financials: Revenue & Earnings
TRDA$4.82+0.41 +9.30%
$187.67M
Market Cap
—
P/E
—
Forward P/E
—
Score
Entrada Therapeutics (TRDA) Financials: Revenue & Earnings
TRDA price $4.82 +0.41 +9.30%
- Ticker
- TRDA
- Price
- $4.82
- Change
- +0.41 +9.30%
- Market cap ?
- $187.67M
- Beta ?
- -0.24
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
TRDA fair value $65.67. Price $4.82. Price is 93% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.98 | — | 2.13M |
| 2026-08-05 | -1.01 | -1.05 | 898.00K | 2.23M |
| 2026-05-07 | -0.95 | -1.06 | 875.00K | 2.92M |
| 2026-02-26 | -0.94 | -1.32 | 1.30M | 7.41M |
| 2025-11-06 | -1.06 | -1.04 | 1.61M | 8.49M |
| 2025-08-06 | -1.04 | -0.86 | 1.95M | 7.83M |
| 2025-05-08 | -0.42 | -0.78 | 20.56M | 9.77M |
| 2025-02-27 | 0.03 | -0.66 | 37.40M | 13.12M |
| 2024-11-05 | -0.35 | -0.67 | 19.57M | 12.92M |
| 2024-08-13 | 1.55 | 0.14 | 94.69M | 12.32M |
| 2024-05-07 | 0.68 | -0.59 | 59.12M | 14.98M |
| 2024-03-13 | -0.29 | -0.07 | 41.85M | 23.69M |
| 2023-11-07 | 1.02 | -0.74 | 43.73M | 21.41M |
| 2023-08-08 | -0.78 | -0.43 | 18.17M | 9.78M |
| 2023-05-10 | -0.21 | -0.77 | 25.26M | 9.78M |
| 2023-03-06 | -0.79 | -0.84 | — | 119.00M |
| 2022-11-07 | -0.80 | -0.76 | — | — |
| 2022-08-11 | -0.74 | -0.72 | — | — |
| 2022-05-12 | -0.69 | -0.65 | — | — |
| 2022-03-15 | -0.89 | -1.28 | — | — |
| 2021-12-09 | -9.78 | -0.87 | — | — |
| 2021-11-01 | -0.48 | — | — | — |
| 2021-03-31 | -0.41 | — | — | — |
| 2020-12-31 | -0.42 | — | — | — |
| 2020-09-30 | -0.34 | — | — | — |
| 2020-06-30 | -5.18 | — | — | — |
| 2020-03-31 | -5.18 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-09 | MPM BIOVENTURES 2018, L.P. | Sell | 28.84K | $7.13 | 205.61K |
| 2026-09-09 | MPM BioVentures 2014, L.P. | Sell | 28.84K | $7.13 | 205.61K |
| 2026-09-08 | MPM BIOVENTURES 2018, L.P. | Sell | 192.50K | $7.41 | 1.43M |
| 2026-09-08 | MPM BioVentures 2014, L.P. | Sell | 192.50K | $7.41 | 1.43M |
| 2026-09-04 | MPM BIOVENTURES 2018, L.P. | Sell | 38.50K | $7.11 | 273.74K |
| 2026-09-04 | MPM BioVentures 2014, L.P. | Sell | 38.50K | $7.11 | 273.74K |
| 2026-09-03 | MPM BIOVENTURES 2018, L.P. | Sell | 32.26K | $7.17 | 231.33K |
| 2026-09-03 | MPM BioVentures 2014, L.P. | Sell | 32.26K | $7.17 | 231.33K |
| 2026-09-02 | MPM BIOVENTURES 2018, L.P. | Sell | 25.13K | $7.19 | 180.69K |
| 2026-09-02 | MPM BioVentures 2014, L.P. | Sell | 25.13K | $7.19 | 180.69K |
| 2026-09-02 | Doshi Dipal | Sell | 8.72K | $7.14 | 62.32K |
| 2026-09-02 | Dowden Nathan J | Sell | 2.53K | $7.14 | 18.06K |
| 2026-09-02 | Sethuraman Natarajan | Sell | 2.08K | $7.14 | 14.85K |
| 2026-09-02 | WENTWORTH KORY JAMES | Sell | 1.73K | $7.14 | 12.38K |
| 2026-09-01 | MPM BIOVENTURES 2018, L.P. | Sell | 29.09K | $7.06 | 205.36K |
| 2026-09-01 | MPM BioVentures 2014, L.P. | Sell | 29.09K | $7.06 | 205.36K |
| 2026-08-31 | MPM BIOVENTURES 2018, L.P. | Sell | 44.26K | $6.99 | 309.37K |
| 2026-08-31 | MPM BioVentures 2014, L.P. | Sell | 44.26K | $6.99 | 309.37K |
| 2026-08-28 | MPM BIOVENTURES 2018, L.P. | Sell | 3.73K | $7.01 | 26.17K |
| 2026-08-28 | MPM BioVentures 2014, L.P. | Sell | 3.73K | $7.01 | 26.17K |
| 2026-08-27 | MPM BIOVENTURES 2018, L.P. | Sell | 38.92K | $7.20 | 280.24K |
| 2026-08-27 | MPM BioVentures 2014, L.P. | Sell | 38.92K | $7.20 | 280.24K |
| 2026-08-26 | MPM BioVentures 2014, L.P. | Sell | 14.57K | $7.06 | 102.86K |
| 2026-08-26 | MPM BIOVENTURES 2018, L.P. | Sell | 14.57K | $7.06 | 102.86K |
| 2026-08-25 | MPM BioVentures 2014, L.P. | Sell | 26.52K | $7.54 | 199.98K |
| 2026-08-25 | MPM BIOVENTURES 2018, L.P. | Sell | 26.52K | $7.54 | 199.98K |
| 2026-08-24 | MPM BioVentures 2014, L.P. | Sell | 21.62K | $7.34 | 158.71K |
| 2026-08-24 | MPM BIOVENTURES 2018, L.P. | Sell | 21.62K | $7.34 | 158.71K |
| 2026-08-10 | PARMAR KUSH | Sell | 92.44K | $7.00 | 647.11K |
| 2026-08-07 | PARMAR KUSH | Sell | 52.32K | $6.85 | 358.37K |
| 2026-08-07 | 5AM Ventures V, L.P. | Sell | 52.32K | $6.85 | 358.37K |
| 2026-08-06 | PARMAR KUSH | Sell | 10.49K | $7.00 | 73.46K |
| 2026-08-06 | 5AM Ventures V, L.P. | Sell | 10.49K | $7.00 | 73.46K |
| 2026-07-31 | 5AM Ventures V, L.P. | Sell | 1.72K | $6.85 | 11.77K |
| 2026-07-31 | PARMAR KUSH | Sell | 1.72K | $6.85 | 11.77K |
| 2026-07-30 | 5AM Ventures V, L.P. | Sell | 114.76K | $6.93 | 795.26K |
| 2026-07-30 | PARMAR KUSH | Sell | 114.76K | $6.93 | 795.26K |
| 2026-06-10 | PARMAR KUSH | Buy | 19.00K | $5.97 | 113.43K |
| 2026-06-10 | KIM PETER S | Buy | 19.00K | $5.97 | 113.43K |
| 2026-06-10 | Chapman Gina | Buy | 19.00K | $5.97 | 113.43K |
| 2026-06-10 | Radhakrishnan Maha | Buy | 19.00K | $5.97 | 113.43K |
| 2026-06-10 | Thistle Mary | Buy | 19.00K | $5.97 | 113.43K |
| 2026-06-10 | Zeiher Bernhardt G | Buy | 19.00K | $5.97 | 113.43K |
| 2026-05-20 | Zeiher Bernhardt G | Buy | 5.00K | $5.86 | 29.32K |
| 2026-05-04 | Sethuraman Natarajan | Sell | 25.91K | $15.39 | 398.81K |
| 2026-05-04 | Dowden Nathan J | Buy | 15.00K | $1.74 | 26.10K |
| 2026-05-04 | Dowden Nathan J | Sell | 15.00K | $15.33 | 229.95K |
| 2026-05-04 | Dowden Nathan J | Sell | 15.00K | $1.74 | 26.10K |
| 2026-04-01 | WENTWORTH KORY JAMES | Sell | 2.50K | $12.95 | 32.38K |
| 2026-03-10 | Dowden Nathan J | Sell | 11.89K | $13.05 | 155.19K |
| 2026-03-10 | WENTWORTH KORY JAMES | Sell | 11.39K | $13.02 | 148.22K |
| 2026-03-09 | Dowden Nathan J | Sell | 3.12K | $13.02 | 40.58K |
| 2026-03-09 | WENTWORTH KORY JAMES | Sell | 5.09K | $13.00 | 66.16K |
| 2026-03-04 | WENTWORTH KORY JAMES | Sell | 7.99K | $12.25 | 97.89K |
| 2026-03-03 | Doshi Dipal | Sell | 19.18K | $11.76 | 225.50K |
| 2026-03-03 | WENTWORTH KORY JAMES | Sell | 5.71K | $11.76 | 67.15K |
| 2026-03-03 | Dowden Nathan J | Sell | 14.04K | $11.76 | 165.04K |
| 2026-03-03 | Sethuraman Natarajan | Sell | 7.58K | $11.76 | 89.08K |
| 2026-03-02 | Doshi Dipal | Sell | 9.87K | $11.66 | 115.05K |
| 2026-03-02 | WENTWORTH KORY JAMES | Sell | 2.94K | $11.66 | 34.26K |
| 2026-03-02 | Dowden Nathan J | Sell | 7.22K | $11.66 | 84.21K |
| 2026-03-02 | Sethuraman Natarajan | Sell | 3.90K | $11.66 | 45.44K |
| 2026-03-01 | Doshi Dipal | Buy | 139.40K | — | — |
| 2026-03-01 | Doshi Dipal | Buy | 208.00K | $11.93 | 2.48M |
| 2026-03-01 | WENTWORTH KORY JAMES | Buy | 44.60K | — | — |
| 2026-03-01 | WENTWORTH KORY JAMES | Buy | 66.60K | $11.93 | 794.54K |
| 2026-03-01 | Dowden Nathan J | Buy | 55.80K | — | — |
| 2026-03-01 | Dowden Nathan J | Buy | 83.20K | $11.93 | 992.58K |
| 2026-03-01 | Sethuraman Natarajan | Buy | 55.80K | — | — |
| 2026-03-01 | Sethuraman Natarajan | Buy | 83.20K | $11.93 | 992.58K |
| 2025-11-21 | WENTWORTH KORY JAMES | Sell | 8.91K | $9.98 | 88.93K |
| 2025-11-20 | BAKER BROS. ADVISORS LP | Buy | 13.08K | $9.07 | 118.69K |
| 2025-11-20 | BAKER BROS. ADVISORS LP | Buy | 13.39K | $9.07 | 121.39K |
| 2025-11-20 | BAKER BROS. ADVISORS LP | Buy | 1.19K | $9.07 | 10.76K |
| 2025-11-20 | BAKER BROS. ADVISORS LP | Buy | 1.21K | $9.07 | 11.00K |
| 2025-11-14 | PARMAR KUSH | Sell | 200.00K | $8.80 | 1.76M |
| 2025-11-14 | 5AM Ventures V, L.P. | Sell | 200.00K | $8.80 | 1.76M |
| 2025-11-12 | BAKER BROS. ADVISORS LP | Buy | 11.49K | $7.95 | 91.43K |
| 2025-11-12 | BAKER BROS. ADVISORS LP | Buy | 80.88K | $7.73 | 625.33K |
| 2025-11-12 | BAKER BROS. ADVISORS LP | Buy | 1.04K | $7.95 | 8.27K |
| 2025-11-12 | BAKER BROS. ADVISORS LP | Buy | 7.32K | $7.73 | 56.60K |
| 2025-11-11 | BAKER BROS. ADVISORS LP | Buy | 30.88K | $7.54 | 232.81K |
| 2025-11-11 | BAKER BROS. ADVISORS LP | Buy | 11.70K | $7.39 | 86.48K |
| 2025-11-11 | BAKER BROS. ADVISORS LP | Buy | 2.79K | $7.54 | 21.07K |
| 2025-11-11 | BAKER BROS. ADVISORS LP | Buy | 1.06K | $7.39 | 7.83K |
| 2025-11-10 | BAKER BROS. ADVISORS LP | Buy | 2.95K | $7.22 | 21.29K |
| 2025-11-10 | BAKER BROS. ADVISORS LP | Buy | 25.36K | $7.21 | 182.97K |
| 2025-11-10 | BAKER BROS. ADVISORS LP | Buy | 267 | $7.22 | 1.93K |
| 2025-11-10 | BAKER BROS. ADVISORS LP | Buy | 2.30K | $7.21 | 16.56K |
| 2025-09-02 | Doshi Dipal | Sell | 8.72K | $5.43 | 47.37K |
| 2025-09-02 | Dowden Nathan J | Sell | 1.75K | $5.43 | 9.48K |
| 2025-09-02 | Sethuraman Natarajan | Sell | 1.76K | $5.43 | 9.56K |
| 2025-09-02 | WENTWORTH KORY JAMES | Sell | 1.73K | $5.43 | 9.42K |
| 2025-07-09 | PARMAR KUSH | Sell | 20.07K | $7.50 | 150.53K |
| 2025-07-09 | PARMAR KUSH | Sell | 6.93K | $7.50 | 52.03K |
| 2025-07-09 | 5AM Ventures V, L.P. | Sell | 20.07K | $7.50 | 150.53K |
| 2025-07-09 | 5AM Ventures V, L.P. | Sell | 6.93K | $7.50 | 52.03K |
| 2025-07-01 | PARMAR KUSH | Sell | 18.58K | $7.12 | 132.32K |
| 2025-07-01 | PARMAR KUSH | Sell | 6.42K | $7.12 | 45.74K |
| 2025-07-01 | 5AM Ventures V, L.P. | Sell | 18.58K | $7.12 | 132.32K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 130, holders +11 vs prior quarter. Ownership 69.35%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 5.07M | 0 | 0.00% | 37.34M |
| 5AM VENTURE MANAGEMENT, LLC | 4.06M | 0 | 0.00% | 29.85M |
| BLACKROCK, INC. | 2.58M | 224.54K | +9.52% | 19.01M |
| MERCK & CO., INC. | 1.74M | 1.74M | New | 12.80M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.27M | 13.62K | +1.08% | 9.34M |
| MPM BIOIMPACT LLC | 1.25M | 1.25M | New | 9.22M |
| TCG CROSSOVER MANAGEMENT, LLC | 1.06M | -1.23M | -53.65% | 7.80M |
| WELLINGTON MANAGEMENT GROUP LLP | 954.42K | -80.36K | -7.77% | 7.02M |
| MILLENNIUM MANAGEMENT LLC | 763.96K | 244.60K | +47.10% | 5.62M |
| STEPSTONE GROUP LP | 761.28K | 0 | 0.00% | 5.60M |
| GEODE CAPITAL MANAGEMENT, LLC | 717.43K | 50.08K | +7.50% | 5.28M |
| AQR CAPITAL MANAGEMENT LLC | 699.54K | 620.04K | +780.00% | 5.15M |
| STATE STREET CORP | 596.68K | 62.88K | +11.78% | 4.39M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 542.32K | 16.27K | +3.09% | 3.99M |
| JPMORGAN CHASE & CO | 496.46K | 481.61K | +3243.82% | 3.83M |
| ACADIAN ASSET MANAGEMENT LLC | 400.86K | 67.69K | +20.32% | 2.94M |
| CITADEL ADVISORS LLC | 394.32K | 179.31K | +83.39% | 2.90M |
| DIMENSIONAL FUND ADVISORS LP | 376.14K | 51.66K | +15.92% | 2.77M |
| NORTHERN TRUST CORP | 309.94K | 74.95K | +31.89% | 2.28M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 303.46K | -30.45K | -9.12% | 2.23M |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 300.57K | 141.24K | +88.65% | 2.21M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 254.13K | 33.64K | +15.25% | 1.87M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 197.14K | -17.61K | -8.20% | 1.45M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 197.14K | 197.14K | New | 1.45M |
| LONGAEVA PARTNERS L.P. | 195.24K | -9.74K | -4.75% | 1.44M |
Earnings and financials
Entrada Therapeutics, Inc. (TRDA) trades at $4.82, with a market cap of $187.67M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn